Benjamin Li
Jul 15, 2013

Ethical grounding likely to help minimise GSK fallout in China

BEIJING – PR industry observers suggest that recent confessions by GlaxoSmithKline (GSK) executives to involvement in bribery and tax offences in China are unlikely to prove a long-term setback for the company.

GSK is under investigation for malpractice in China

Please sign in or register

Access limited free articles a month after free, fast registration.

Existing users sign in here

Forgotten Password?

Having trouble signing in?

Contact Customer Support at
[email protected]
or call+852 3175 1913

Related Articles

Just Published

22 hours ago

Agency Report Card 2024: Dentsu Media

Dentsu Media navigated a turbulent 2024, marked by financial pressures, leadership instability, and structural reorganisation, even as it pushed forward with AI investments and selective market successes.

22 hours ago

Agency Report Cards 2024: We grade 25 APAC networks

The grades are in for Campaign Asia's 22nd annual evaluation of APAC agency networks. Subscribe to read our detailed analyses.

1 day ago

Google enhances ads portfolio with new AI-powered ...

The tech giant unveiled a series of updates to Google Ads, analytics and search, including launching agentic AI tools.